These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22294022)

  • 1. Aciclovir and valaciclovir neurotoxicity in patients with renal failure.
    Ruiz-Roso G; Gomis A; Fernández-Lucas M; Díaz-Domínguez M; Teruel-Briones JL; Quereda C
    Nefrologia; 2012; 32(1):114-5. PubMed ID: 22294022
    [No Abstract]   [Full Text] [Related]  

  • 2. Warning against unexpected medication in haemodialysis.
    Quiñones Ortiz L; Suárez Laurés A; Pobes Martínez A; de la Torre M; Torres Lacalle A; Forascepi Roza R
    Nefrologia; 2011; 31(5):611-2. PubMed ID: 21959734
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of baclofen overdose by haemodialysis: a pharmacokinetic study.
    Wu VC; Lin SL; Lin SM; Fang CC
    Nephrol Dial Transplant; 2005 Feb; 20(2):441-3. PubMed ID: 15615812
    [No Abstract]   [Full Text] [Related]  

  • 4. Precipitation of a psychoneuromotor syndrome by fluoxetine in a haloperidol-treated schizophrenic patient.
    D'Souza DC; Bennett A; Abi-Dargham A; Krystal JH
    J Clin Psychopharmacol; 1994 Oct; 14(5):361-3. PubMed ID: 7806697
    [No Abstract]   [Full Text] [Related]  

  • 5. Baclofen neurotoxicity in a patient with end-stage chronic renal failure.
    Justo-Ávila P; Fernández-Antuña L; Compte-Jove MT; Gállego-Gil C
    Nefrologia; 2014; 34(4):536-8. PubMed ID: 25036073
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral acyclovir and neurologic adverse effects in endstage renal disease.
    Mataix AL; Duarte J; Revuelta K; Fuentes MJ; Ruiz MD; Gavira R; López MC
    Ann Pharmacother; 1994; 28(7-8):961-2. PubMed ID: 7949522
    [No Abstract]   [Full Text] [Related]  

  • 7. Baclofen Toxicity in Kidney Disease.
    Wolf E; Kothari NR; Roberts JK; Sparks MA
    Am J Kidney Dis; 2018 Feb; 71(2):275-280. PubMed ID: 28899601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A possible baclofen-induced neurotoxicity in a CAPD patient who recovered with long-duration hemodialysis.
    Wu CC; Lin SH
    Perit Dial Int; 2002; 22(2):279-80. PubMed ID: 11990422
    [No Abstract]   [Full Text] [Related]  

  • 9. Treating baclofen overdose by hemodialysis.
    Hsieh MJ; Chen SC; Weng TI; Fang CC; Tsai TJ
    Am J Emerg Med; 2012 Oct; 30(8):1654.e5-7. PubMed ID: 22030181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is extracorporeal treatment useful for managing severe baclofen poisoning even on patients with normal renal function? Indeed a very open debate!
    Vandroux D; Gaüzère BA; Martinet O
    Anaesth Crit Care Pain Med; 2016 Jun; 35(3):229. PubMed ID: 26931742
    [No Abstract]   [Full Text] [Related]  

  • 11. [Toxic effects of baclofen in a patient with chronic renal insufficiency].
    Kroczak M; Rakus A
    Przegl Lek; 2001; 58(4):364-6. PubMed ID: 11450371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anesthetic risks in renal failure.
    Stetson JB; Wise W
    Int J Artif Organs; 1981 Jul; 4(4):153-5. PubMed ID: 7327756
    [No Abstract]   [Full Text] [Related]  

  • 13. Is extracorporeal treatment useful for managing severe baclofen poisoning? - The debate is still open.
    Mégarbane B; Labat L; Declèves X
    Anaesth Crit Care Pain Med; 2016 Apr; 35(2):171-2. PubMed ID: 26852828
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolonged unconsciousness in a patient on automated peritoneal dialysis.
    Lois F; Wallemacq P; de Tourtchaninoff M; Vanbinst R; Laterre PF; Goffin E; Hantson P
    Eur J Emerg Med; 2006 Dec; 13(6):361-3. PubMed ID: 17091060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Electroencephalographic burst-suppression pattern due to baclofen intoxication].
    Montes MI; Hernández Ortiz OH; Guerra Palacio A
    Med Intensiva; 2011 Dec; 35(9):584-6. PubMed ID: 21497413
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of valaciclovir dosage reduction in continuous ambulatory peritoneal dialysis patients.
    Stathoulopoulou F; Dhillon S; Thodis H; Stathakis C; Vargemezis V
    Nephron; 2002 May; 91(1):164-6. PubMed ID: 12021536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Summaries for patients. Quinine and thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
    Ann Intern Med; 2001 Dec; 135(12):S-65. PubMed ID: 11785472
    [No Abstract]   [Full Text] [Related]  

  • 18. Encephalopathy in chronic renal failure responsive to deferoxamine therapy. Another manifestation of aluminum neurotoxicity.
    Sprague SM; Corwin HL; Wilson RS; Mayor GH; Tanner CM
    Arch Intern Med; 1986 Oct; 146(10):2063-4. PubMed ID: 3767553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodialysis removal of acyclovir.
    Leikin JB; Shicker L; Orlowski J; Blair AT; McAllister K
    Vet Hum Toxicol; 1995 Jun; 37(3):233-4. PubMed ID: 7571352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baclofen toxicity in patients with severely impaired renal function.
    Chen KS; Bullard MJ; Chien YY; Lee SY
    Ann Pharmacother; 1997 Nov; 31(11):1315-20. PubMed ID: 9391686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.